Microcurrent Therapy and Low-Level Laser Therapy on Wound Healing

Wound Healing Delayed Clinical Trial

Official title:

Microcurrent Therapy Versus Low-Level Laser Therapy on Post-surgical Wound Healing

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05326022
• Other study ID #: P.T.REC/012/002599
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 28, 2022
• Est. completion date: October 30, 2022

Study information

• Verified date: April 2022
• Source: South Valley University
• Contact: Nehad A. Abo-Zaid, PhD
• Phone: +201223265216
• Email: dr.nehadahmed[@]svu.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study aiming to compare between the Microcurrent and Low-Level Laser Therapy on wound healing

Description:

The study designed to compare between the Microcurrent and Low-Level Laser Therapy on wound healing

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 90
• Est. completion date: October 30, 2022
• Est. primary completion date: September 30, 2022
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 10 Years to 50 Years

Eligibility

Inclusion Criteria:

• patient recently undergo appendectomy

Exclusion Criteria:

• patient with neurological disorders
• patient with metabolic disorders

Related Conditions & MeSH terms

• Wound Healing Delayed
• Wounds and Injuries

Intervention

Device:
• Microcurrent therapy
Microcurrent therapy
• Low Level Laser Therapy
Laser therapy

Other:
• Medical therapy
Medical therapy

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Nehad Ahmed Youness Abo-zaid

References & Publications (1)

Dickinson LE, Gerecht S. Engineered Biopolymeric Scaffolds for Chronic Wound Healing. Front Physiol. 2016 Aug 5;7:341. doi: 10.3389/fphys.2016.00341. eCollection 2016. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	levels of matrix metalloproteinases	analyze by Enzyme-linked immunosorbent assay	assessed at day 3 post operative
Secondary	levels of matrix metalloproteinases	analyze by Enzyme-linked immunosorbent assay	assessed at day 30 post operative
Secondary	the tissue inhibitors of metalloproteinases	analyze by Enzyme-linked immunosorbent assay	assessed at day 3 post operative
Secondary	the tissue inhibitors of metalloproteinases	analyze by Enzyme-linked immunosorbent assay	assessed at day 30 post operative